Analysis of the <i>p53</i> and <i>MDM‐2</i> gene in acute myeloid leukemia
Barbara Seliger(Johannes Gutenberg University Mainz), Andreas Neubauer(RWTH Aachen University), Christoph Huber(University Hospital of Geneva), Joachim örtel, Cornelia Brendel(Philipps University of Marburg), S. Störkel(University of Münster), Detlef W. Vogel, Karin Kolbe(Johannes Gutenberg University Mainz), D. Huhn(Universität Innsbruck), Stefan Papadileris(Johannes Gutenberg University Mainz), Georg Heß(Johannes Gutenberg University Mainz)
Cited by 55
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573